WorkspaceResearch
HPLPHARMACEUTICALSAlpha Score••Free accountSep-26

Hoehcst Pakistan Ltd

Shariah compliant
Last close
Rs4,000
−0.02%
3 monthsAs of 19 Nov
BusinessGoodGrowthGrew 10%+last yearValueCore planHealthStrongDividendRising

A strong balance sheet, a dividend raised 3 years running and a good business. No read is against it.

Working

  • P/E 11.0 against a sector median of 11.9.
  • Debt is 6% of equity in the latest quarter.
  • Operating margin 18% over the last twelve months, above its average of 14% over the last 3 years.

To watch

  • Rs 621m owed by customers. Collections decide how much of the profit turns into cash.
  • Revenue down 6% on the same quarter last year.
  • Profit down 30% on the same quarter last year.
Full analysis · free account

Keep reading HPL: business, price trend and value

How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.

Latest results

Quarter: Jul–Sep 2026

In the Jul–Sep 2026 quarter, HPL's sales fell 6% to Rs 7.8bn, from Rs 8.3bn, and profit after tax fell 30% to Rs 616.0mn, from Rs 876.0mn (compared with Jul–Sep 2025).

Earnings per share were Rs 63.87, against Rs 90.79 a year earlier.

At Rs 3999.89, HPL trades at 10.4 times earnings, with a dividend yield of 6.8%.

P/E ratio
10.4
Dividend yield
6.8%
Dividend payout
0%
of earnings
Return on equity
42%
Net margin
11.0%
last 12 months
Debt to equity
0.06

HPL quarterly results

Reported figures
QuarterSalesProfit after taxNet marginEPSDividend / share
Jul–Sep 2026Rs 7.8bnRs 616.0mn7.9%Rs 63.87—
Apr–Jun 2026Rs 9.0bnRs 1.5bn16.4%Rs 152.94Rs 80.00
Jan–Mar 2026Rs 7.7bnRs 721.0mn9.4%Rs 74.71—
Oct–Dec 2025Rs 6.4bnRs 690.0mn10.8%Rs 71.54Rs 190.00
Jul–Sep 2025Rs 8.3bnRs 876.0mn10.6%Rs 90.79—
Apr–Jun 2025Rs 8.7bnRs 790.0mn9.1%Rs 81.94Rs 50.00
Jan–Mar 2025Rs 7.6bnRs 554.0mn7.3%Rs 57.40—
Oct–Dec 2024Rs 6.2bnRs 654.0mn10.5%Rs 67.63Rs 110.00

HPL annual results and dividends

Reported figures
YearSalesProfit after taxEPSDividend / share
Year to Dec 2025Rs 30.9bnRs 2.9bnRs 301.67Rs 240.00
Year to Dec 2024Rs 26.7bnRs 1.9bnRs 192.56Rs 135.00
Year to Dec 2023Rs 21.4bnRs 361.0mnRs 37.41Rs 30.00
Year to Dec 2022Rs 18.6bnRs 167.0mnRs 17.29—
Year to Dec 2021Rs 15.9bnRs 906.0mnRs 93.93Rs 30.00

Balance sheet and price

Balance sheet as of Sep 2026
Total assets
Rs 15.8bn
Shareholders' equity
Rs 8.4bn
Cash & bank
Rs 141.9mn
Total debt
Rs 470.7mn
Current ratio
1.70
3-month high
Rs 4150.04
3-month low
Rs 3861.54
1-month change
-1.4%
3-month change
-0.1%

Read more about HPL

Other pharmaceuticals companies

HPL: common questions

What is HPL's share price?

Hoehcst Pakistan Ltd (HPL) last closed at Rs 3999.89 on the Pakistan Stock Exchange.

Does HPL pay a dividend?

Yes. Hoehcst Pakistan Ltd paid Rs 240.00 per share for the year to Dec 2025, and the stock's dividend yield is 6.8%.

What were HPL's latest results?

In the Jul–Sep 2026 quarter, HPL's sales fell 6% to Rs 7.8bn, from Rs 8.3bn, and profit after tax fell 30% to Rs 616.0mn, from Rs 876.0mn (compared with Jul–Sep 2025).

What is HPL's P/E ratio?

At Rs 3999.89, HPL trades at 10.4 times its earnings.

Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.